Which has better valuation and earnings, WAT or BRKR?

Waters has higher earnings, but lower revenue than Bruker. Bruker is trading at a lower price-to-earnings ratio than Waters, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Waters $3.17B 11.78 $642.63M $7.87 48.25 Bruker $3.44B 2.78 -$8.60M -$0.24 N/A

Is WAT or BRKR more profitable?

Waters has a net margin of 11.91% compared to Bruker's net margin of -0.65%. Waters' return on equity of 15.60% beat Bruker's return on equity. Company Net Margins Return on Equity Return on Assets Waters 11.91% 15.60% 8.90% Bruker -0.65% 11.60% 4.25%

Does the media favor WAT or BRKR?

In the previous week, Waters had 10 more articles in the media than Bruker. MarketBeat recorded 18 mentions for Waters and 8 mentions for Bruker. Waters' average media sentiment score of 0.59 beat Bruker's score of 0.54 indicating that Waters is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Waters 6 Very Positive mention(s) 2 Positive mention(s) 7 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Bruker 1 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Which has preferable valuation & earnings, TECH or WAT?

Waters has higher revenue and earnings than Bio-Techne. Waters is trading at a lower price-to-earnings ratio than Bio-Techne, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Bio-Techne $1.22B 6.53 $73.40M $0.69 73.70 Waters $3.17B 11.78 $642.63M $7.87 48.25

Is TECH or WAT more profitable?

Waters has a net margin of 11.91% compared to Bio-Techne's net margin of 9.05%. Waters' return on equity of 15.60% beat Bio-Techne's return on equity. Company Net Margins Return on Equity Return on Assets Bio-Techne 9.05% 13.57% 10.66% Waters 11.91% 15.60% 8.90%

Does the media prefer A or WAT?

In the previous week, Agilent Technologies had 23 more articles in the media than Waters. MarketBeat recorded 41 mentions for Agilent Technologies and 18 mentions for Waters. Agilent Technologies' average media sentiment score of 0.77 beat Waters' score of 0.59 indicating that Agilent Technologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Agilent Technologies 16 Very Positive mention(s) 6 Positive mention(s) 11 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive Waters 6 Very Positive mention(s) 2 Positive mention(s) 7 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has better earnings and valuation, WAT or DHR?

Danaher has higher revenue and earnings than Waters. Danaher is trading at a lower price-to-earnings ratio than Waters, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Waters $3.17B 11.78 $642.63M $7.87 48.25 Danaher $24.57B 5.14 $3.61B $5.17 34.51

Is WAT or DHR more profitable?

Danaher has a net margin of 14.89% compared to Waters' net margin of 11.91%. Waters' return on equity of 15.60% beat Danaher's return on equity. Company Net Margins Return on Equity Return on Assets Waters 11.91% 15.60% 8.90% Danaher 14.89% 10.91% 6.94%

Does the media prefer WAT or DHR?

In the previous week, Danaher had 2 more articles in the media than Waters. MarketBeat recorded 20 mentions for Danaher and 18 mentions for Waters. Danaher's average media sentiment score of 0.80 beat Waters' score of 0.59 indicating that Danaher is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Waters 6 Very Positive mention(s) 2 Positive mention(s) 7 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Danaher 10 Very Positive mention(s) 0 Positive mention(s) 8 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive

Which has better earnings & valuation, IQV or WAT?

IQVIA has higher revenue and earnings than Waters. IQVIA is trading at a lower price-to-earnings ratio than Waters, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio IQVIA $16.31B 1.86 $1.36B $8.07 22.57 Waters $3.17B 11.78 $642.63M $7.87 48.25

Is IQV or WAT more profitable?

Waters has a net margin of 11.91% compared to IQVIA's net margin of 8.33%. IQVIA's return on equity of 30.50% beat Waters' return on equity. Company Net Margins Return on Equity Return on Assets IQVIA 8.33% 30.50% 6.53% Waters 11.91% 15.60% 8.90%

Does the media refer more to IQV or WAT?

In the previous week, Waters had 10 more articles in the media than IQVIA. MarketBeat recorded 18 mentions for Waters and 8 mentions for IQVIA. Waters' average media sentiment score of 0.59 beat IQVIA's score of 0.10 indicating that Waters is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment IQVIA 0 Very Positive mention(s) 3 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Waters 6 Very Positive mention(s) 2 Positive mention(s) 7 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Waters (WAT) Competitors

$379.76 +7.83 (+2.10%)

Closing price 03:58 PM Eastern

Extended Trading

$380.01 +0.25 (+0.07%)

As of 07:58 PM Eastern

Compare

WAT vs. BRKR, TECH, A, DHR, and IQV

Should you buy Waters stock or one of its competitors? MarketBeat compares Waters with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Waters include Bruker (BRKR), Bio-Techne (TECH), Agilent Technologies (A), Danaher (DHR), and IQVIA (IQV).

How does Waters compare to Bruker?

Waters (NYSE:WAT) and Bruker (NASDAQ:BRKR) are both life sciences tools & services companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, media sentiment, risk, institutional ownership, profitability, valuation and earnings.

In the previous week, Waters had 10 more articles in the media than Bruker. MarketBeat recorded 18 mentions for Waters and 8 mentions for Bruker. Waters' average media sentiment score of 0.59 beat Bruker's score of 0.54 indicating that Waters is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Waters	6 Very Positive mention(s)	2 Positive mention(s)	7 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Bruker	1 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

94.0% of Waters shares are owned by institutional investors. Comparatively, 79.5% of Bruker shares are owned by institutional investors. 0.3% of Waters shares are owned by company insiders. Comparatively, 27.2% of Bruker shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Waters currently has a consensus price target of $394.24, indicating a potential upside of 3.81%. Bruker has a consensus price target of $50.54, indicating a potential downside of 19.40%. Given Waters' stronger consensus rating and higher possible upside, equities research analysts clearly believe Waters is more favorable than Bruker.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Waters	0 Sell rating(s)	8 Hold rating(s)	9 Buy rating(s)	3 Strong Buy rating(s)	2.75
Bruker	2 Sell rating(s)	6 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.40

Waters has a net margin of 11.91% compared to Bruker's net margin of -0.65%. Waters' return on equity of 15.60% beat Bruker's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Waters	11.91%	15.60%	8.90%
Bruker	-0.65%	11.60%	4.25%

Waters has a beta of 1.21, suggesting that its share price is 21% more volatile than the broader market. Comparatively, Bruker has a beta of 1.31, suggesting that its share price is 31% more volatile than the broader market.

Waters has higher earnings, but lower revenue than Bruker. Bruker is trading at a lower price-to-earnings ratio than Waters, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Waters	$3.17B	11.78	$642.63M	$7.87	48.25
Bruker	$3.44B	2.78	-$8.60M	-$0.24	N/A

Summary

Waters beats Bruker on 14 of the 17 factors compared between the two stocks.

How does Waters compare to Bio-Techne?

Bio-Techne (NASDAQ:TECH) and Waters (NYSE:WAT) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, profitability, media sentiment, risk, valuation, dividends and earnings.

Bio-Techne has a beta of 1.37, suggesting that its stock price is 37% more volatile than the broader market. Comparatively, Waters has a beta of 1.21, suggesting that its stock price is 21% more volatile than the broader market.

In the previous week, Waters had 17 more articles in the media than Bio-Techne. MarketBeat recorded 18 mentions for Waters and 1 mentions for Bio-Techne. Bio-Techne's average media sentiment score of 1.89 beat Waters' score of 0.59 indicating that Bio-Techne is being referred to more favorably in the media.

Company	Overall Sentiment
Bio-Techne	Very Positive
Waters	Positive

99.0% of Bio-Techne shares are held by institutional investors. Comparatively, 94.0% of Waters shares are held by institutional investors. 1.3% of Bio-Techne shares are held by company insiders. Comparatively, 0.3% of Waters shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Bio-Techne currently has a consensus price target of $65.92, suggesting a potential upside of 29.64%. Waters has a consensus price target of $394.24, suggesting a potential upside of 3.81%. Given Bio-Techne's stronger consensus rating and higher probable upside, analysts clearly believe Bio-Techne is more favorable than Waters.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bio-Techne	0 Sell rating(s)	4 Hold rating(s)	9 Buy rating(s)	1 Strong Buy rating(s)	2.79
Waters	0 Sell rating(s)	8 Hold rating(s)	9 Buy rating(s)	3 Strong Buy rating(s)	2.75

Waters has a net margin of 11.91% compared to Bio-Techne's net margin of 9.05%. Waters' return on equity of 15.60% beat Bio-Techne's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Bio-Techne	9.05%	13.57%	10.66%
Waters	11.91%	15.60%	8.90%

Waters has higher revenue and earnings than Bio-Techne. Waters is trading at a lower price-to-earnings ratio than Bio-Techne, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bio-Techne	$1.22B	6.53	$73.40M	$0.69	73.70
Waters	$3.17B	11.78	$642.63M	$7.87	48.25

Summary

Bio-Techne and Waters tied by winning 8 of the 16 factors compared between the two stocks.

How does Waters compare to Agilent Technologies?

Agilent Technologies (NYSE:A) and Waters (NYSE:WAT) are both large-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, institutional ownership, profitability, dividends, analyst recommendations, risk, media sentiment and valuation.

In the previous week, Agilent Technologies had 23 more articles in the media than Waters. MarketBeat recorded 41 mentions for Agilent Technologies and 18 mentions for Waters. Agilent Technologies' average media sentiment score of 0.77 beat Waters' score of 0.59 indicating that Agilent Technologies is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Agilent Technologies	16 Very Positive mention(s)	6 Positive mention(s)	11 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive
Waters	6 Very Positive mention(s)	2 Positive mention(s)	7 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Agilent Technologies has a beta of 1.26, suggesting that its stock price is 26% more volatile than the broader market. Comparatively, Waters has a beta of 1.21, suggesting that its stock price is 21% more volatile than the broader market.

94.0% of Waters shares are held by institutional investors. 0.3% of Waters shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Agilent Technologies has higher revenue and earnings than Waters. Agilent Technologies is trading at a lower price-to-earnings ratio than Waters, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Agilent Technologies	$6.95B	5.61	$1.30B	$4.98	27.71
Waters	$3.17B	11.78	$642.63M	$7.87	48.25

Agilent Technologies currently has a consensus price target of $161.71, indicating a potential upside of 17.18%. Waters has a consensus price target of $394.24, indicating a potential upside of 3.81%. Given Agilent Technologies' stronger consensus rating and higher possible upside, research analysts plainly believe Agilent Technologies is more favorable than Waters.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Agilent Technologies	0 Sell rating(s)	2 Hold rating(s)	13 Buy rating(s)	1 Strong Buy rating(s)	2.94
Waters	0 Sell rating(s)	8 Hold rating(s)	9 Buy rating(s)	3 Strong Buy rating(s)	2.75

Agilent Technologies has a net margin of 19.55% compared to Waters' net margin of 11.91%. Agilent Technologies' return on equity of 24.33% beat Waters' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Agilent Technologies	19.55%	24.33%	12.99%
Waters	11.91%	15.60%	8.90%

Summary

Agilent Technologies beats Waters on 11 of the 17 factors compared between the two stocks.

How does Waters compare to Danaher?

Waters (NYSE:WAT) and Danaher (NYSE:DHR) are both large-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, institutional ownership, analyst recommendations, dividends, media sentiment, profitability, risk and earnings.

Danaher has higher revenue and earnings than Waters. Danaher is trading at a lower price-to-earnings ratio than Waters, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Waters	$3.17B	11.78	$642.63M	$7.87	48.25
Danaher	$24.57B	5.14	$3.61B	$5.17	34.51

Danaher has a net margin of 14.89% compared to Waters' net margin of 11.91%. Waters' return on equity of 15.60% beat Danaher's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Waters	11.91%	15.60%	8.90%
Danaher	14.89%	10.91%	6.94%

In the previous week, Danaher had 2 more articles in the media than Waters. MarketBeat recorded 20 mentions for Danaher and 18 mentions for Waters. Danaher's average media sentiment score of 0.80 beat Waters' score of 0.59 indicating that Danaher is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Waters	6 Very Positive mention(s)	2 Positive mention(s)	7 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Danaher	10 Very Positive mention(s)	0 Positive mention(s)	8 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive

Waters has a beta of 1.21, indicating that its stock price is 21% more volatile than the broader market. Comparatively, Danaher has a beta of 0.81, indicating that its stock price is 19% less volatile than the broader market.

Waters currently has a consensus price target of $394.24, indicating a potential upside of 3.81%. Danaher has a consensus price target of $235.14, indicating a potential upside of 31.81%. Given Danaher's stronger consensus rating and higher possible upside, analysts plainly believe Danaher is more favorable than Waters.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Waters	0 Sell rating(s)	8 Hold rating(s)	9 Buy rating(s)	3 Strong Buy rating(s)	2.75
Danaher	0 Sell rating(s)	4 Hold rating(s)	20 Buy rating(s)	0 Strong Buy rating(s)	2.83

94.0% of Waters shares are held by institutional investors. Comparatively, 79.1% of Danaher shares are held by institutional investors. 0.3% of Waters shares are held by insiders. Comparatively, 10.8% of Danaher shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

Danaher beats Waters on 9 of the 17 factors compared between the two stocks.

How does Waters compare to IQVIA?

IQVIA (NYSE:IQV) and Waters (NYSE:WAT) are both large-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, profitability, dividends, valuation, institutional ownership, analyst recommendations, earnings and risk.

IQVIA currently has a consensus price target of $224.13, indicating a potential upside of 23.06%. Waters has a consensus price target of $394.24, indicating a potential upside of 3.81%. Given IQVIA's stronger consensus rating and higher possible upside, equities analysts clearly believe IQVIA is more favorable than Waters.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
IQVIA	0 Sell rating(s)	2 Hold rating(s)	13 Buy rating(s)	2 Strong Buy rating(s)	3.00
Waters	0 Sell rating(s)	8 Hold rating(s)	9 Buy rating(s)	3 Strong Buy rating(s)	2.75

In the previous week, Waters had 10 more articles in the media than IQVIA. MarketBeat recorded 18 mentions for Waters and 8 mentions for IQVIA. Waters' average media sentiment score of 0.59 beat IQVIA's score of 0.10 indicating that Waters is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
IQVIA	0 Very Positive mention(s)	3 Positive mention(s)	4 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Waters	6 Very Positive mention(s)	2 Positive mention(s)	7 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Waters has a net margin of 11.91% compared to IQVIA's net margin of 8.33%. IQVIA's return on equity of 30.50% beat Waters' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
IQVIA	8.33%	30.50%	6.53%
Waters	11.91%	15.60%	8.90%

89.6% of IQVIA shares are owned by institutional investors. Comparatively, 94.0% of Waters shares are owned by institutional investors. 1.7% of IQVIA shares are owned by company insiders. Comparatively, 0.3% of Waters shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

IQVIA has higher revenue and earnings than Waters. IQVIA is trading at a lower price-to-earnings ratio than Waters, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
IQVIA	$16.31B	1.86	$1.36B	$8.07	22.57
Waters	$3.17B	11.78	$642.63M	$7.87	48.25

IQVIA has a beta of 1.21, meaning that its stock price is 21% more volatile than the broader market. Comparatively, Waters has a beta of 1.21, meaning that its stock price is 21% more volatile than the broader market.

Summary

IQVIA and Waters tied by winning 8 of the 16 factors compared between the two stocks.

Get Waters News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding WAT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

WAT vs. The Competition

Export

Metric	Waters	MED INSTRUMENTS Industry	Medical Sector	NYSE Exchange
Market Cap	$36.52B	$7.25B	$6.47B	$23.28B
Dividend Yield	N/A	1.23%	2.69%	4.06%
P/E Ratio	48.25	36.99	18.89	28.24
Price / Sales	11.78	74.02	520.79	23.82
Price / Cash	22.37	24.22	41.34	24.93
Price / Book	8.83	7.15	9.84	4.67
Net Income	$642.63M	$159.22M	$3.57B	$1.07B
7 Day Performance	10.71%	0.91%	-1.16%	-0.67%
1 Month Performance	23.61%	3.99%	3.85%	0.22%
1 Year Performance	8.59%	1.56%	27.40%	25.44%

Waters Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
WAT Waters	2.7243 of 5 stars	$379.76 +2.1%	$394.24 +3.8%	+8.3%	$36.52B	$3.17B	48.25	7,900	Trending News Analyst Upgrade
BRKR Bruker	1.846 of 5 stars	$45.69 flat	$50.54 +10.6%	+56.0%	$6.96B	$3.44B	N/A	11,085	Analyst Forecast
TECH Bio-Techne	4.1236 of 5 stars	$48.21 flat	$65.92 +36.7%	+2.4%	$7.55B	$1.22B	69.87	3,100	Positive News
A Agilent Technologies	4.6917 of 5 stars	$115.01 +0.0%	$163.71 +42.4%	+21.7%	$32.49B	$6.95B	25.39	18,100	Earnings Report Analyst Forecast
DHR Danaher	4.7276 of 5 stars	$172.12 +0.1%	$238.65 +38.7%	-6.9%	$121.74B	$24.57B	33.29	60,000	Analyst Downgrade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:WAT) was last updated on 6/3/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Waters (WAT) Competitors